Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.5000 (-1.61%) ($5.5000 - $5.5000) on Mon. Jun. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.76% (three month average) | RSI | 72 | Latest Price | $5.5000(-1.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 10.8% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(5%) SLV(-12%) SDY(90%) REMX(-30%) XLU(38%) | Factors Impacting CAPR price | CAPR will decline at least -2.38% in a week (0% probabilities). IWO(28%) JETS(-7%) IWM(30%) IWN(33%) GDXJ(26%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.38% (StdDev 4.76%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $5.51(-0.18%) | 10 Day Moving Average | $5.25(4.76%) | 20 Day Moving Average | $4.77(15.3%) | To recent high | -3.7% | To recent low | 8.2% | Market Cap | $108m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |